2022
DOI: 10.1016/j.medine.2021.02.008
|View full text |Cite
|
Sign up to set email alerts
|

Predictive factors of six-week mortality in critically ill patients with SARS-CoV-2: A multicenter prospective study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 55 publications
(54 reference statements)
0
2
0
Order By: Relevance
“…After screening by abstract and title, 571 articles were selected for full-text assessment. In total, 157 studies evaluating 948,309 patients were included in the meta-analysis (9–159). The characteristics of all the included studies are shown in Table S1 (http://links.lww.com/CCX/B152).…”
Section: Resultsmentioning
confidence: 99%
“…After screening by abstract and title, 571 articles were selected for full-text assessment. In total, 157 studies evaluating 948,309 patients were included in the meta-analysis (9–159). The characteristics of all the included studies are shown in Table S1 (http://links.lww.com/CCX/B152).…”
Section: Resultsmentioning
confidence: 99%
“…Regarding antibiotic use, we found that the group that died had a significantly higher percentage of use of antibiotics, whereas other cohorts found no differences among groups. [ 27 ] On the other hand, immunomodulatory treatment with tocilizumab was utilized only in 2.3% of participants in the survival group and 3.8% in non-survivors. This is intriguing because, by May 2021, the RECOVERY trial proved the efficacy of tocilizumab to improve survival and other clinical outcomes in patients with hypoxia and systemic inflammation.…”
Section: Discussionmentioning
confidence: 99%